12 participants
A Clinical Study to Evaluate the Safety and Immunogenicity of a Higher Dose of the Study Vaccine, VIR-1388, in HCMV-seropositive Adult Participants Without HIV
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-03
- Start Date:
- 2026-10-15
- Completion:
- 2028-02-02
Conditions
- Cytomegalovirus (CMV)
- HIV (Human Immunodeficiency Virus)
Interventions
- BIOLOGICAL
No Results Yet